Abstract
Glioblastoma multiformes (GBMs) are recurring brain tumors containing self-renewing glioma stem cells (GSCs), which contribute to tumor initiation and therapy resistance. These tumors are heterogeneous in cellular composition and are highly invasive. In addition, their ability to invade surrounding tissue away from the tumor core makes this cancer difficult to treat. Until recently, the methods for culturing GSCs and studying their invasion patterns were not modeled in human-relevant culture systems. We describe a protocol that constitutes multiple assays to study GSC invasion into human brain-like tissue organoids derived from iPSCs. These methods can be easily adopted in an existing cell culture lab facility. This chapter aims to provide researchers with detailed step-by-step procedure for generating 3D brain organoids and different assay methods to study invasion patterns of patient-derived GSCs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Álvarez-Satta M, Matheu A (2018) Primary cilium and glioblastoma. Ther Adv Med Oncol 10:1758835918801169
Hubert CG et al (2016) A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res 76:2465–2477
Johnson DR, O’Neill BP (2012) Glioblastoma survival in the United States before and during the temozolomide era. J Neuro-Oncol 107:359–364
Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352(10):987–996
Darmanis S et al (2017) Single-cell RNA-seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep 21:1399–1410
Jacob F et al (2020) A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180:188–204.e22
Mandel JJ et al (2018) Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro-Oncology 20:113–122
Neftel C et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178:835–849.e21
Prager BC et al (2019) Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell 24(1):41–53
Lathia JD et al (2015) Cancer stem cells in glioblastoma. Genes Dev 29(12):1203–1217
Garnier D et al (2018) Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization. Neuro-Oncology 20:236–248
Piper K et al (2021) Glioma stem cells as immunotherapeutic targets: advancements and challenges. Front Oncol 11:1–13
Goranci-Buzhala G et al (2020) Rapid and efficient invasion assay of glioblastoma in human brain organoids. Cell Rep 31:107738
Pernik MN et al (2021) Patient-derived cancer organoids for precision oncology treatment. J Pers Med 11:423
Silvia N, Dai G (2020) Cerebral organoids as a model for glioblastoma multiforme. Curr Opin Biomed Eng 13:152–159
Gómez-Oliva R et al (2021) Evolution of experimental models in the study of glioblastoma: toward finding efficient treatments. Front Oncol 10:614295
Torsvik A et al (2014) U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med 3(4):812–824
Lee J et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9(5):391–403
**e Y et al (2015) The human glioblastoma cell culture resource: validated cell models representing all molecular subtypes. EBioMedicine 2(10):1351–1363
Marziali G et al (2017) A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Mol Oncol 11(9):1115–1129
Tentler JJ et al (2012) Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9(6):338–350
Schmid RS, Vitucci M, Miller CR (2012) Genetically engineered mouse models of diffuse gliomas. Brain Res Bull 88(1):72–79
Shou Y et al (2020) The application of brain organoids: from neuronal development to neurological diseases. Front Cell Dev Biol 8:579659
Qian X, Song H, Ming GL (2019) Brain organoids: advances, applications and challenges. Development 146(8):dev166074
Gabriel E et al (2020) Human brain organoids to decode mechanisms of microcephaly. Front Cell Neurosci 14:115
Linkous A et al (2019) Modeling patient-derived glioblastoma with cerebral organoids. Cell Rep 26(12):3203–3211 e5
Ogawa J et al (2018) Glioblastoma model using human cerebral organoids. Cell Rep 23(4):1220–1229
Rybin MJ et al (2021) Organoid models of glioblastoma and their role in drug discovery. Front Cell Neurosci 15:605255
Goranci-Buzhala G et al (2020) Rapid and efficient invasion assay of glioblastoma in human brain organoids. Cell Rep 31(10):107738
Lenting K et al (2017) Glioma: experimental models and reality. Acta Neuropathol 133(2):263–282
Boye K et al (2017) The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors. Nat Commun 8(1):1571
Klingberg A et al (2017) Fully automated evaluation of total glomerular number and capillary tuft size in nephritic kidneys using lightsheet microscopy. J Am Soc Nephrol 28(2):452–459
Gabriel E et al (2016) CPAP promotes timely cilium disassembly to maintain neural progenitor pool. EMBO J 35(8):803–819
Pacioni S et al (2015) Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts. Stem Cell Res Ther 6(1) https://doi.org/10.1186/s13287-015-0185-z
Acknowledgments
We thank Dr. Boris Görg for offering generous support with their microscope facility. The development of the techniques described in this book chapter was financially supported by grants from Deutsche Forschungsgemeinschaft (DFG) (GO 2301/2-2) and the Fritz-Thyssen Foundation to J.G. and from AIRC (IG 2019 number 23154) to R.P.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mariappan, A., Knauth, T., Pallini, R., Gopalakrishnan, J. (2023). A Three-Dimensional Organoid Culture System to Model Invasive Patterns of Patient-Derived Glioma Stem Cells. In: Gopalakrishnan, J. (eds) Brain Organoid Research. Neuromethods, vol 189. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2720-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2720-4_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2719-8
Online ISBN: 978-1-0716-2720-4
eBook Packages: Springer Protocols